The current price of NNOX is $0.2483 — it has decreased by 11.95% since the previous close. Data as of Nov 5, 2026.
NNOX is down 16.45% over the past week, down 59.65% over the past month and down 92.12% over the past year. The price is below its 200-day moving average of $1.56.
Analysts' average 12-month price target for NNOX is $3.00, which implies 1,108.22% upside from the current price. Individual estimates range from $3.00 to $3.00.
Of the 3 analysts covering Nano-X Imaging Ltd., 2 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Nano-X Imaging Ltd. has a market capitalization of $19.51M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Nano-X Imaging Ltd. posted a loss of $0.79 per share against an estimate of -$0.162, missing expectations by 387.56%. Upcoming reports are listed in the earnings calendar.
Nano-X Imaging Ltd. reported revenue of $4.16M in its most recent quarter, which has increased by 36.71% compared with the same quarter a year earlier. Analysts had expected $5.38M.
Nano-X Imaging Ltd. has not paid any dividends over the past year.
Companies most comparable to Nano-X Imaging Ltd. include Profound Medical Corp., TriSalus Life Sciences, Inc., Inogen, Inc., MaxCyte, Inc. and Quanterix Corporation.
In the latest trading session NNOX moved between $0.2403 and $0.2897, a range of 19.90% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Nano-X Imaging Ltd. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Nano-X Imaging Ltd. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks NNOX has traded between $0.2403 and $4.71. The current price is 94.73% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.